Change over period
From:
To:
Zoom:
- 3M
- 6M
- YTD
- 1Y
- 3Y
- 5Y
- 10Y
- 15Y
- 20Y
- Max
Helius Medical Technologies Inc Class A
NASDAQ HSDT
Data sourced from
and
and
Download Data
Helius Medical Technologies Inc Class A Price to Earnings Ratio (P/E) on June 03, 2024: -2.15
Helius Medical Technologies Inc Class A Price to Earnings Ratio (P/E) is -2.15 on June 03, 2024, a -439.23% change year over year. The price to earnings ratio (P/E ratio) compares the market price per share of a company's stock to its earnings per share (EPS). It is calculated by dividing the market capitalization by the net income, divided by the number of outstanding shares. This ratio provides insights into the market's valuation of a company's earnings. A higher P/E ratio indicates that investors are willing to pay a higher price for each unit of earnings, suggesting higher market expectations for future earnings growth.
-
Helius Medical Technologies Inc Class A 52-week high Price to Earnings Ratio (P/E) is -0.37 on June 09, 2023, which is 82.57% above the current Price to Earnings Ratio (P/E).
-
Helius Medical Technologies Inc Class A 52-week low Price to Earnings Ratio (P/E) is -585.10 on August 08, 2023, which is -27,124.91% below the current Price to Earnings Ratio (P/E).
-
Helius Medical Technologies Inc Class A average Price to Earnings Ratio (P/E) for the last 52 weeks is -16.78.
Don’t Miss A Beat
Looking to stay ahead of the competition and stay informed? Receive your daily dose of market news, trends, and analysis to kickstart your day and stay up-to-date.
NASDAQ: HSDT
| CEO | Mr. Dane Carl Andreeff |
| IPO Date | June 27, 2014 |
| Location | United States |
| Headquarters | 642 Newtown Yardley Road, Newtown, PA, United States, 18940 |
| Employees | 22 |
| Sector | Healthcare |
| Industry | Medical devices |
Description
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.
Key trends
StockViz Staff
September 16, 2024
Any question? Send us an email